Sell Your Veterinary Practice in Michigan in 2026: 5-13x by Tier, PE Platforms, CPVM Structure

Selling your veterinary practice in Michigan in 2026 clears 5-7x EBITDA at the single-DVM lifestyle tier, 7-9.5x at 2-3 DVM general practice scale, 9.5-11.5x at the $1M-$3M EBITDA 4-8 DVM PE platform sweet spot (clean books to 12x), and 11-13x at $3M+ multi-doctor specialty scale. Detroit and Grand Rapids density supports platform-quality deals, plus Michigan 4.25% flat income tax on the gain shapes after-tax proceeds. Active Michigan buyers include Mars Veterinary Health, NVA/Ethos, Mission Pet Health, VetCor, PetVet Care Centers, Heartland.

If you own a veterinary practice in Michigan, your seat in the national consolidation wave is better than the state population trend suggests. Cumulative private-equity investment in US veterinary reached $51.6 billion across 2017 to 2023, with another $9.3 billion in the first four months of 2024 (American Economic Liberties Project), and PE buyers supplied roughly 80% of 2024 deal capital. What makes Michigan distinctive is that one of the five largest national platforms, Mission Pet Health, keeps its corporate headquarters in Novi in the Detroit suburbs and was itself assembled in 2017 from two Michigan hospital groups, so a seller in the southern Lower Peninsula is negotiating on a buyer home ground rather than against a single out-of-state bidder.

This guide is written for the Michigan DVM who wants the price and the path, not boilerplate. It covers 2026 multiples by EBITDA tier, the wellness-plan premium that moves general-practice value most, the named consolidators with clinics already on Michigan ground, and the parts of a Michigan deal that depart from the national template: the Michigan Board of Veterinary Medicine licensing under Public Health Code Part 188, the quieter reason Michigan is a restricted state for non-veterinarian ownership (the Business Corporation Act professional-corporation rule, not the veterinary act itself), the non-compete standard under MCL 445.774a, and the flat 4.25% Michigan income tax that decides how much of the check you keep.

CT Acquisitions runs confidential, buy-side processes. No fee to you on buy-side introductions; sell-side mandates are paid on success at closing. For wider context, see our veterinary hub guide, our Private Equity in Veterinary 2026 report, our national guide to selling a veterinary practice, our specialty hospital guide, and our 36-month veterinary practice exit playbook. The free valuation survey takes about three minutes.

How Michigan veterinary practices are valued in 2026, the tiered framework

Michigan veterinary practices are priced off adjusted EBITDA and sorted into size tiers, the national structure read against a southern-corridor bidder pool that is unusually deep for a non-coastal state. A one-DVM lifestyle or rural mixed-animal clinic under $500K of adjusted EBITDA sits below the floor where corporate diligence pays for itself, so it tends to change hands between DVMs. Move up the tiers and the Detroit-to-Grand Rapids corridor starts bidding.

Michigan veterinary practices are priced off adjusted EBITDA and sorted into size tiers, the same structure buyers apply nationally but read against a southern-corridor bidder pool anchored by an in-state platform headquarters. A one-DVM lifestyle or rural mixed-animal clinic under $500K of adjusted EBITDA sits below the threshold where corporate diligence pays for itself and usually clears 5x to 7x, trading between doctors or small regional groups rather than going to a platform. A two-to-three-DVM general practice at $500K to $1M of adjusted EBITDA lands in the 7x to 9.5x range, with the top of that band earned by high-margin books that do not lean on a single doctor. The four-to-eight-DVM hospital at $1M to $3M is where the corridor platforms compete hardest and clears 9.5x to 11.5x, reaching 12x when the books are clean and a second-tier doctor bench is in place. Above $3M, usually a multi-doctor specialty or referral group, pricing runs 11x to 13x and can stretch to 16x to 18x for a marquee specialty hospital an aggregator wants for geographic fill. Specialty, emergency and 24/7 hospitals carry a 1.5x to 3x premium over general practice. R.L. Hulett Q1 2025 Pet M&A Update reported closed transactions spanning 6x to 16x adjusted EBITDA, and per the American Economic Liberties Project private-equity buyers supplied roughly 80% of 2024 veterinary deal capital. A wellness-plan book above 15% of eligible general-practice cases routinely adds 0.5x to 1.5x on top of the size-tier baseline.

Michigan practice profile	Typical multiple	What moves it in Michigan
Single-DVM lifestyle / rural mixed-animal under $500K EBITDA	5-7x EBITDA	Below the platform diligence floor; sells DVM-to-DVM, common in the northern Lower Peninsula and the UP
2-3 DVM general practice ($500K-$1M EBITDA)	7-9.5x EBITDA	Draws Detroit, Ann Arbor and Grand Rapids bidders even at modest scale
4-8 DVM hospital ($1M-$3M EBITDA)	9.5-11.5x EBITDA (clean books to 12x)	The tier Novi-based Mission Pet Health and national tuck-in buyers compete for; associate bench and wellness penetration set the top end
$3M+ EBITDA multi-doctor / specialty / referral	11-13x EBITDA (16-18x for marquee specialty)	Oakland County and Grand Rapids referral catchment carries it; BluePearl and Ethos compete for the cases
Multi-site groups (3+ hospitals)	12-15x EBITDA	Southern-corridor density commands platform-of-platform pricing

The lever that separates a floor multiple from a corridor multiple is competition. A four-doctor Michigan hospital with $1.5M of EBITDA taken quietly to one strategic buyer might settle at 9.5x to 10.5x, roughly $14M to $16M. Placed into a competitive process across the platforms that already operate around Detroit, Ann Arbor and Grand Rapids, that same hospital pulls a second and third bidder, and a buyer who marks tuck-ins up on its own balance sheet will pay one to two turns more to win the geography.

How does the wellness-plan / membership premium affect Michigan veterinary practice valuation?

For a Michigan general practice, the wellness-plan book is the single change an owner can make that moves the multiple most. Recurring monthly membership revenue turns transactional cash flow into something a buyer can underwrite as predictable, and every corridor consolidator now expects it.

For a Michigan general practice, the wellness-plan book is the single change an owner can make that moves the multiple most. Practice-management software vendors put plan penetration above 18% of eligible patients across the US, and members spend two to three times what non-plan clients do, so a healthy book converts transactional cash flow into monthly recurring revenue that buyers value more highly because it smooths seasonality, signals retention, and supports a defensible lifetime-value calculation after close. Banfield built the model at scale with its Optimum Wellness Plans, and the groups buying in Michigan, from Novi-based Mission Pet Health and VetCor to the national GP consolidators, expect an acquired hospital to be on a branded plan within a year to eighteen months. To capture the premium in a Michigan process, stand the plan up 18 to 24 months before going to market, push penetration past 12 to 15% of eligible general-practice cases, break the recurring revenue out as its own line in the financial pack, and carry it into the quality-of-earnings report as a distinct book. Michigan hospitals that arrive at market above 20% penetration with average member tenure past two years regularly clear 75 to 150 basis points above their size-tier baseline. The mirror image is the risk: a purely transactional Michigan practice with thin repeat visits gets marked down in the same diligence.

What do Michigan platform buyers underwrite regarding earnouts and DVM retention?

In Michigan deals, as everywhere in veterinary, the binding constraint a buyer underwrites is doctor retention, not patient demand, so the structure leans on the seller and the associate bench staying put. Corridor buyers pay strong cash at close but hold a slice against clinical continuity.

In Michigan deals, as everywhere in veterinary, the binding constraint a buyer underwrites is doctor retention rather than patient demand, so the structure leans on the seller and the associate bench staying put. A typical Michigan two-to-eight-DVM hospital sold to a platform closes on roughly 70 to 80% cash, with 10 to 20% rolled into equity in a Newco or a platform-level holding company and 5 to 15% held as an earnout keyed to the selling doctor clinical hours through years one to three, associate retention through years one to two, and trailing-twelve EBITDA holding its baseline. Above $5M of enterprise value the rollover slice usually rises to 20 to 30%. Because Michigan is a restricted-ownership state, that rollover is almost always into the management company, the MSO, rather than into the professional corporation that must stay in a licensed veterinarian hands. The recurring fight is production-comp normalization: many Michigan owners run associate pay at 20 to 25% of production plus distributions, while platforms reset associates to 22 to 24% straight production with no profit share and then recompute adjusted EBITDA on that basis, so agreeing a ProSal floor with the buyer six to twelve months before signing heads off the haircut. The clawbacks have teeth: a typical structure fires if the selling DVM drops under 32 hours a week or under 80% of historical production for any 60-day window in the earnout period, and an associate departure inside 18 months releases part of the escrow back to the buyer. Relief-doctor hours through IndeVets, Roo and similar staffing services generally do not count toward the production thresholds.

How much multiple expansion can you achieve through platform-versus-tuck-in arbitrage in Michigan?

The gap between what a platform pays for a single Michigan hospital and what that hospital is worth once it sits inside a larger group is the reason the buyers keep coming back to the southern corridor. That spread is where the premium a seller can capture actually lives.

The gap between what a platform pays for a single Michigan hospital and what that hospital is worth once it sits inside a larger group is the reason the buyers keep returning to Detroit, Ann Arbor and Grand Rapids. A standalone four-doctor Michigan general practice at $1.5M of EBITDA sold direct might clear 9.5x to 10.5x. Tucked into a group that itself trades at a 15x to 18x platform multiple, the same earnings get re-marked at five to seven turns higher on the acquirer books, which is why groups such as Mission Pet Health and VetCor will pay 11x to 12x for a $1M to $2M Michigan hospital they want. The catch for a Michigan seller is that the premium only shows up when the buyer actually wants your geography or species mix. An off-thesis hospital, wrong corner of the state, wrong case load, or soft earnings quality, gets the floor multiple regardless of how many platforms exist. That is where the corridor helps: because several buyers already operate in the southern Lower Peninsula, and one of the largest is headquartered in Novi, a Michigan owner who runs four to six of them in parallel is far more likely to find the one for whom the practice is on-thesis, and to convert that into one or two extra turns. Tighter acquisition-debt markets through 2024 and 2025 trimmed platform multiples by a turn or two from the 2021 to 2022 peak, and the late-2025 rate cuts have restarted committed financing, which is part of why Michigan buyers are active again in 2026.

Who is buying Michigan veterinary practices in 2024-2026, named platforms with CURRENT ownership

The Michigan buyer pool is the national buyer pool with its single most important member headquartered in-state. It splits into Mars permanent capital, roughly 15 private-equity-backed national platforms, and the doctor-controlled alternatives, with Mission Pet Health run out of Novi giving Michigan a home-state anchor.

The Michigan buyer pool is the national buyer pool with its most consequential member headquartered inside the state. It splits into Mars permanent capital, roughly 15 private-equity-backed national platforms, and the doctor-controlled alternatives. Mission Pet Health is the Michigan anchor: backed by Shore Capital Partners, it reached roughly 750 clinics after the July 2025 merger of Mission Veterinary Partners and Southern Veterinary Partners, and it keeps its corporate headquarters in Novi in the Detroit suburbs, having been built in 2017 from two Michigan groups, Advanced Animal Hospital Group and Progressive Pet Animal Hospitals. VetCor, led by Oak Hill Capital with Harvest Partners and Cressey & Co., holds a hospital in Troy and has been among the most active general-practice tuck-in buyers nationally. Mars Veterinary Health is the single largest buyer, folding VCA, Banfield and the BluePearl specialty and emergency network under one strategic, permanent-capital umbrella rather than a fund. NVA sits under JAB Holding Company with its Ethos specialty and emergency division, and the 2022 FTC consent order from the SAGE deal still restricts JAB specialty and ER acquisitions within 25 miles of an existing JAB clinic in California and Texas. PetVet Care Centers has been owned by KKR since 2022, not Onex. Heartland Veterinary Partners is now Gryphon Investors majority after its 2024 to 2025 recap, not American Securities, and runs out of Chicago within reach of the Michigan market. AmeriVet is held by AEA Investors and the Abu Dhabi Investment Authority since the February 2022 recap, not Imperial Capital. Other national platforms in the pool include Veterinary Practice Partners (Audax), Innovetive Petcare (Metalmark), United Veterinary Care (Nordic Capital, not Atlantic Street), Suveto (Levine Leichtman, not LongueVue), Veritas (Percheron), Encore Vet Group (North Castle), Rarebreed (Revelstoke), Bond Vet (Warburg Pincus urgent care), VetEvolve (Varsity Healthcare) and Thrive Pet Healthcare (TSG Consumer). The doctor-controlled route is open to Michigan owners too: MedVet is roughly 95% DVM and employee owned with a Leonard Green minority, and Galaxy Vets is the first US consolidator built as an employee stock ownership plan, both for owners who want liquidity without handing clinical control to a fund.

How are different veterinary sub-verticals valued in Michigan?

Buyers rank Michigan veterinary sub-verticals on a clear hierarchy. General practice is the backbone of the platform thesis; specialty and referral sit at the top of the multiple range, and the Detroit and Grand Rapids referral markets give Michigan solid specialty demand.

Buyers rank Michigan veterinary sub-verticals on a clear hierarchy. General practice is the backbone of the platform thesis at 5x to 12x adjusted EBITDA by size, with buyers favoring two-to-eight-DVM hospitals that carry a stable associate bench, own or control their real estate, and run a wellness book. Specialty and referral practices, covering surgery, internal medicine, oncology, cardiology, neurology, dermatology and ophthalmology, trade highest at 11x to 14x and up to 16x to 18x for a marquee multi-specialist hospital with strong referral catchment. Michigan supports real specialty bidding because the Detroit and Grand Rapids markets concentrate referral volume and Mars BluePearl competes with NVA Ethos for the same cases. Emergency, urgent-care and 24/7 hospitals carry 11x to 13x on the scarcity of overnight staffing and the specialty cross-sell, with BluePearl, Bond Vet and the regional ER groups leading that lane. Mixed-animal, equine and food-animal practices, more common in the agricultural west and the northern Lower Peninsula, are a separate buyer pool at 5x to 8x, since production-animal economics, travel logistics and USDA APHIS oversight do not standardize well at platform level and the buyers tend to be other large-animal DVMs or regional groups. Mobile and house-call practices are capital-light but doctor-time-bound with little platform appetite because there is no real-estate moat. Multi-site groups of three or more hospitals are the single most attractive Michigan archetype, since the southern corridor gives buyers regional density and a pipeline of further tuck-ins, and they pay platform-of-platform multiples of 12x to 15x for it.

Our national data on veterinary practice valuation multiples shows what buyers actually pay by tier.

What is the Michigan veterinary market context in 2026?

Michigan restricts non-veterinarian ownership, but through a quiet mechanism that sellers often misread: the veterinary act is silent, and the limit comes from the professional-corporation rule in the Business Corporation Act. Platform activity concentrates in the Detroit-to-Grand Rapids corridor, de-risked by Michigan State in-state DVM pipeline.

Michigan is a restricted-ownership state, but not for the reason most sellers assume. The Michigan veterinary practice act, Public Health Code Part 188 at MCL 333.18801 through 333.18838, bars practicing veterinary medicine without a license yet says nothing directly about who may own a practice. The restriction instead comes from corporate law: because veterinary medicine is a licensed health profession, a practice organized as a professional corporation must comply with the Business Corporation Act professional-corporation rule at MCL 450.1283, which requires each shareholder to be a licensed person in a professional service the corporation provides and restricts how shares may transfer. The practical result is that a non-veterinarian or private-equity buyer cannot simply hold the practice entity, so Michigan deals run through a friendly-PC plus MSO structure. Demand concentrates where the people and the doctors are. Metro Detroit, at roughly 4.4 million people, anchors the deepest bidder bench, Grand Rapids near 1.2 million anchors a second west-Michigan market, and Ann Arbor and Lansing are reachable satellites, with Mission Pet Health headquartered in Novi inside that band. Michigan State College of Veterinary Medicine in East Lansing, the only veterinary school in the state, graduates roughly 115 to 120 DVMs a year and sits about an hour from both Detroit and Grand Rapids, feeding an in-state associate pipeline that lowers the staffing risk buyers weigh most heavily near the metros. Statewide population growth is slow, a mild Rust Belt headwind buyers underwrite cautiously, but the affluent Oakland County suburbs, Ann Arbor university wealth, and healthier-growth Grand Rapids supply the premium-spend pockets that general-practice roll-ups pay up for.

Which buyers are actually near your Michigan practice, and what your location does to your negotiating position

The Lower Peninsula’s southern corridor (Detroit – Ann Arbor – Grand Rapids) is a real buyer market anchored by an in-state platform HQ; the Upper Peninsula is a different, isolated world.

• Mission Veterinary Partners / Mission Pet Health: Novi (national HQ), Michigan hospital cluster (MVP was formed in 2017 from two Michigan-based groups, Advanced Animal Hospital Group and Progressive Pet Animal Hospitals; individual current MI hospital cities not enumerated because the public locations database was offline for the merger)
• VetCor: Troy

Your location scored on five factors

Proximity to an existing platform is the hook, but it only converts if you clear the size bar, and three more factors, metro depth, DVM labor supply, and the demand trend, decide how hard buyers actually compete. Here is how Michigan reads on all five.

Factor	What it means for your exit
Buyers near you	Unusually strong for a non-coastal state at its core: Mission Pet Health (a top-5 US platform) is HEADQUARTERED in Novi (Detroit metro) and was built from Michigan hospital groups, and VetCor holds Troy, so a southern-Lower-Peninsula seller sits on a platform’s home turf with national buyers also reaching in; the Upper Peninsula, ~6.5-7hr and a bridge away, has essentially none.
Your size gate	In metro Detroit / Oakland County / Ann Arbor / Lansing a platform can bolt on even a solid solo or two-DVM practice with local infrastructure, so the bar is low-to-moderate; in the UP and far north the bar rises sharply and sub-scale practices trade to local/regional buyers, not platforms.
Metro depth	Detroit (~4.39M) anchors a genuinely deep bench and Grand Rapids (~1.2M) a second west-Michigan market, with Ann Arbor (~0.37M) and Lansing (~0.54M) as reachable mid-size satellites – real multi-bidder potential in the south; the UP is isolated micro-markets.
DVM labor supply	Michigan State’s College of Veterinary Medicine (East Lansing) is a top-3-nationally, only-in-state vet school sitting ~1.25hr from both Detroit and Grand Rapids, materially de-risking staffing across the southern corridor; that advantage does not reach the UP.
Demand trend	Statewide population growth is slow/flat (~28K added in 2025, a mild Rust Belt headwind), but affluent Oakland County suburbs (Birmingham ~$154K, Bloomfield Hills ~$190K median), Ann Arbor’s university wealth, and healthier-growth Grand Rapids provide durable premium-spend pockets against that backdrop.

Michigan’s standout fact is that a top-five national veterinary platform, Mission Pet Health, is headquartered in Novi in metro Detroit and was literally assembled from two Michigan hospital groups, with VetCor also holding Troy – so if your practice is anywhere in the southern Lower Peninsula (metro Detroit, the affluent Oakland County suburbs, Ann Arbor, or Lansing) you are on a buyer’s home turf, and national platforms reach in on top of that. That is real bargaining position, but it is gated by your scale. On the southern corridor that gate is low: a platform can bolt on even a solid solo or two-doctor practice using infrastructure it already runs locally, so most clean practices clear it. Deep in the Upper Peninsula the gate rises sharply – Marquette is six to seven hours and a bridge from Detroit, its only land link runs into Wisconsin, and a buyer there is planting a flag in isolation, not extending a cluster, so a sub-scale UP practice will more likely sell to a local individual than to a national platform.

MSA depth backs the southern story. Detroit-Warren-Dearborn is a large, deep-bench market of about 4.4 million, Grand Rapids anchors a second west-Michigan market near 1.2 million, and Ann Arbor and Lansing are reachable satellites, so a clean multi-DVM practice in the south can realistically draw more than one credible bidder; the UP is a thin one-buyer market. Labor is a genuine tailwind on the corridor: Michigan State runs a top-three-nationally, only-in-state vet college in East Lansing that sits about an hour and a quarter from both Detroit and Grand Rapids, which answers a buyer’s biggest worry – staffing the practice after the founder steps back – though that advantage does not reach the UP. Demand is the mixed factor: statewide Michigan grows slowly, a mild Rust Belt headwind buyers underwrite cautiously, but the affluent Oakland County suburbs (Birmingham and Bloomfield Hills medians of roughly $154K and $190K), Ann Arbor’s university wealth, and healthier-growth Grand Rapids supply the durable premium-spend pockets that GP roll-ups pay up for.

Two Michigan legal points shape the deal. First, Michigan restricts non-veterinarian ownership, so unlike a permissive state a platform cannot simply buy your practice – it must use the friendly-PC plus management-company structure, which makes the DVM-partner selection and management-services-agreement terms central negotiation items (it does not deter the platforms, but it adds structure). Second, Michigan enforces reasonable non-competes under MCL 445.774a, which is more buyer-friendly than near-ban states: expect to be bound to a standard sale non-compete as the selling owner, and know your associates can be held to reasonable covenants too, so the negotiation is over duration and geography, not whether the covenant sticks. Net: the southern Lower Peninsula combines strong proximity (including an in-state platform HQ), a low size gate, deep MSAs, a premier in-state labor pipeline, and affluent demand pockets against a slow-growth statewide backdrop – a solidly seller-favorable market where Grand Rapids adds a growth angle and Oakland County adds an affluence angle; the Upper Peninsula is a scarcity play that rewards a differentiated practice and punishes a sub-scale one.

What should Michigan veterinary sellers know about the ownership rules, premise licenses, and FTC scrutiny?

Selling a Michigan veterinary practice touches three regulatory layers, and the first is the one that shapes the whole deal: Michigan restricts non-veterinarian ownership, so a corporate buyer must use a friendly-PC plus MSO. The layers are the Michigan Board of Veterinary Medicine licensing, federal DEA registration, and the antitrust backdrop.

Selling a Michigan veterinary practice touches three regulatory layers, and the first one defines the structure. Michigan restricts non-veterinarian ownership of a practice. The veterinary act itself, Public Health Code Part 188, is silent on business ownership and simply bars unlicensed practice at MCL 333.18811, but the limit is real because any professional corporation that holds the practice must satisfy the Business Corporation Act professional-corporation rule at MCL 450.1283, under which every shareholder has to be a licensed person in a service the corporation renders and share transfers are restricted. So a private-equity or corporate buyer uses a management-services structure: a Michigan-licensed veterinarian owns the professional corporation that holds the clinical license and employs the doctors, while the buyer owns a separate MSO that holds the non-clinical assets and provides administration under a management services agreement, with a stock-transfer-restriction agreement keeping the PC friendly. The MSO must not control clinical judgment. The friendly-PC-plus-MSO scaffolding typically adds $50K to $150K in transaction legal cost, which is the price of operating in a restricted state. The second layer is federal and unchanged by state law: each location that stores or dispenses controlled substances needs its own DEA registration, the new owner obtains a fresh DEA number, the controlled-substance inventory transfers with a documented count signed by both sides at close, and Schedule II drugs move on DEA Form 222. The third layer is antitrust posture. The 2020 NVA / Compassion-First and 2022 JAB / SAGE FTC consent orders remain in force, the May 2024 FTC and DOJ request for information named veterinary roll-ups as a concern, and a January 2025 FTC settlement signaled that stealth sub-HSR acquisitions in fragmented healthcare verticals are on the agenda, so a deal where the likely Michigan buyer already owns nearby specialty or ER capacity can draw a longer review.

How this applies to a Michigan veterinary practice sale

For a Michigan seller the sequence runs ownership first, then licensing, then federal items, then antitrust. Because Michigan restricts non-veterinarian ownership, the deal is built around a friendly-PC that a licensed Michigan veterinarian owns and an MSO that the buyer owns, so selecting the DVM partner and negotiating the management services agreement are central rather than afterthoughts. Next the practice keeps its Michigan Board of Veterinary Medicine licensing current and notifies the board, housed in LARA Bureau of Professional Licensing, of the ownership change. Then DEA: the new owner secures a fresh DEA registration, the controlled-substance inventory transfers with a signed count, and Schedule II items move on Form 222. Finally antitrust: if the most likely platform bidder already holds specialty or emergency capacity near you, in the Detroit or Grand Rapids clusters especially, build extra review time into the calendar. Plan on roughly 90 to 150 days from signing to close, with the friendly-PC and MSO formation, the DEA reissuance, and any FTC look in specialty-dense pockets as the constraints that set the pace.

What deal mechanics are specific to Michigan veterinary practice sales?

The deal mechanics on a Michigan veterinary sale follow the national pattern with two Michigan-specific bends: the ownership step runs through a friendly-PC plus MSO because Michigan restricts non-veterinarian ownership, and non-compete enforceability runs on the reasonableness standard set in MCL 445.774a.

The deal mechanics on a Michigan veterinary sale follow the national pattern with a couple of Michigan-specific bends. Rollover equity typically runs 20 to 30% of proceeds into the MSO or a platform holding company on deals above $5M of enterprise value, vesting over three to five years and monetizing at the next recap on a four-to-six-year hold. The DVM-retention earnout holds 5 to 15% of consideration against the seller continued clinical hours, associate retention through years one to two, and EBITDA stability, with a clawback if the seller falls under 32 hours a week or under 80% of pre-close production for any 60-day window. Production-comp normalization is the same recut buyers apply everywhere: associates reset to 22 to 24% straight production and adjusted EBITDA is recomputed on that basis, which can trim it 5 to 15% unless the seller pre-empts it. The first Michigan-specific point is the ownership transfer itself. Because the state restricts non-veterinarian ownership, the parties cannot simply assign the practice entity to the buyer; they form a friendly professional corporation owned by a licensed Michigan veterinarian to hold the clinical license, and an MSO owned by the buyer to hold the non-clinical assets and provide management under a long-term services agreement, bound together by a stock-transfer-restriction agreement. The second Michigan-specific point is non-competes. Michigan enforces reasonable covenants under MCL 445.774a, which lets a court enforce a restriction that is reasonable in duration, geography and line of business and lets the court limit an overbroad one rather than void it. Sale-of-business non-competes given by a selling owner are the strongest kind and generally hold; associate covenants are judged on the same reasonableness factors, so the negotiation is over duration and scope, not whether the covenant sticks. Real estate is commonly split into a separate entity at signing and leased back on a 15-to-20-year triple-net lease, leaving veterinary real estate as independent optionality at roughly 5.5% to 7.5% cap rates.

Why is the DVM succession crisis driving Michigan veterinary owners to sell now?

The engine behind the Michigan selling wave is succession, not a doctor shortage. The AAVMC projects enough new graduates to meet aggregate demand, so the real driver is an aging pool of practice owners deciding to step back, and Michigan has a large cohort reaching that decision now.

The engine behind the Michigan selling wave is succession, not a doctor shortage. The 2025 AVMA Report on the Economic State of the Veterinary Profession counts roughly 130,415 DVMs in the US workforce, most in small-animal practice, and the AAVMC 2024 supply-and-demand study concluded that new graduates from existing colleges should meet aggregate demand through the mid-2030s, with real shortfalls concentrated in rural, food-animal and emergency staffing rather than across the board. The more durable driver is demographic. Peer-reviewed survey work published in JAVMA over 2024 and 2025 found that 61% of clinical-practice DVMs intend to cut clinical hours within five years and 31% intend to stop clinical work entirely, and roughly 8% of working veterinarians are already 66 or older. Michigan feels this on two sides at once: its southern-corridor practices sit near a steady Michigan State graduate pipeline that keeps associate supply healthier than in states with no vet school, while its large base of owner-operators who built practices in the 1980s and 1990s is now reaching retirement. With private-equity capital restarted by the late-2025 rate cuts and an in-state platform headquartered in Novi, 2026 through 2030 is the structural window when more Michigan owners cross 60 than at any prior point.

Why does a Michigan veterinary practice sale need vertical-specific advice?

A generalist advisor who treats a Michigan veterinary practice as any other services business will miss the levers that move the price and will misread the Michigan rules, most importantly by overlooking that the ownership restriction here comes from corporate law rather than the veterinary act.

A generalist advisor who treats a Michigan veterinary practice as any other services business will miss the levers that move the price and will misread the local rules. The wellness-plan documentation, the rollover-equity slice that monetizes at the next recap, the 5 to 15% production-comp recut buyers apply to pre-close numbers, the 32-hour and 80%-production earnout thresholds, and the split between enforceable sale-of-business non-competes and more contestable associate covenants are all veterinary-specific diligence items. Two of them are Michigan-specific. The first is that the ownership restriction here is easy to misdiagnose: the veterinary act is silent, so an advisor who only reads Part 188 may wrongly conclude Michigan permits direct corporate ownership, when the Business Corporation Act professional-corporation rule at MCL 450.1283 is what forces the friendly-PC plus MSO structure. The second is that Michigan non-competes turn on the reasonableness standard in MCL 445.774a rather than a bright-line rule, which changes how you draft and how you value doctor retention. A Michigan seller working with someone who knows the current platform cap tables, which buyers already sit in the southern corridor, and how Michigan actually licenses and enforces, negotiates as an equal rather than being educated by the buyer diligence team at their own expense.

What is the 18-24 month pre-sale playbook for Michigan veterinary practices?

Michigan owners who reach the top of their tier prepare deliberately over 12 to 24 months. The priorities are the wellness book, a real associate bench, clean normalized earnings, a current premise license, the friendly-PC and MSO structuring plan, and using the corridor to run a genuine competitive process.

Michigan owners who reach the top of their tier almost always prepared deliberately. With 12 to 24 months of runway, work down this list:

• Stand up a wellness plan 18 to 24 months out. Push penetration past 12 to 15% of eligible cases, break recurring revenue out in the financials, and carry it into the quality-of-earnings report; in a Michigan process this one move can add 75 to 150 basis points over the size-tier baseline.
• Move associates to ProSal six to twelve months before signing. Pre-empting the platform production-comp reset neutralizes the 5 to 15% EBITDA haircut buyers otherwise apply.
• Build the associate bench. A single-DVM practice sits below the platform floor; getting to two or three doctors reaches 7x to 9.5x and four to eight reaches the 9.5x to 11.5x tier, and near Lansing the Michigan State pipeline makes hiring that bench realistic.
• Normalize owner compensation. Set owner W-2 and production at market and let the excess fall to EBITDA, documented in payroll and K-1 detail before diligence starts.
• Plan the friendly-PC and MSO early. Because Michigan restricts non-veterinarian ownership, line up the licensed-DVM partner for the professional corporation and the management services agreement terms before going to market so the structure does not delay close.
• Keep the premise license and DEA clean. A current Michigan Board of Veterinary Medicine license, a clean board record, and an accurate Schedule II inventory are table stakes in Michigan diligence.
• Draft non-competes to the MCL 445.774a standard. Reasonable time and geography that protect a legitimate interest are far more likely to survive a Michigan court than an overbroad covenant, and they reassure the buyer on doctor retention.
• Decide on the real estate. Carving the building into a separate entity and leasing it back on a long triple-net at market rent creates independent optionality at roughly 5.5% to 7.5% cap rates.
• Use the corridor. Because several platforms operate in the southern Lower Peninsula and one is headquartered in Novi, run four to six of them in parallel rather than taking the first inbound offer; competition is what converts proximity into price.

For the broader framework, see our Private Equity in Veterinary 2026 report, our 36-month veterinary exit playbook, and the lower middle market buyer mandate report.

What are the most common mistakes Michigan veterinary practice owners make when selling?

The mistakes that cost Michigan sellers money cluster around anchoring on revenue, missing the production-comp recut, misreading the ownership rule, chasing outdated buyer lists, and taking the first offer when the corridor gives them a real auction.

• Anchoring on revenue instead of adjusted EBITDA, doctor-retention structure and wellness-plan penetration, which are what buyers actually pay for.
• Not modeling the production-comp recut. Platforms reset associates to 22 to 24% straight production and recompute EBITDA, a 5 to 15% cut that is routine unless you pre-empt it.
• Misreading why Michigan is restricted. The veterinary act is silent on ownership, so owners assume direct corporate ownership is fine; the professional-corporation rule at MCL 450.1283 is what forces the friendly-PC plus MSO, and missing it delays close.
• Working an outdated buyer list. PetVet is KKR, not Onex; Heartland is Gryphon, not American Securities; AmeriVet is AEA and ADIA, not Imperial Capital; United Veterinary Care is Nordic Capital, not Atlantic Street; and Suveto is Levine Leichtman, not LongueVue; outreach to stale cap tables wastes runway.
• Overlooking the in-state anchor. Mission Pet Health is headquartered in Novi and VetCor holds Troy, so a southern-corridor seller who markets only to distant national funds leaves the closest, most motivated bidder off the list.
• Drafting non-competes that ignore MCL 445.774a. An overbroad covenant invites a Michigan court to narrow it; a reasonable one protects the buyer and holds up.
• Overlooking the doctor-controlled route. MedVet, roughly 95% DVM and employee owned, and Galaxy Vets, built as an ESOP, are genuine Michigan-accessible options for owners who want liquidity without handing clinical control to a fund.
• Taking the first inbound offer. With multiple platforms in the southern corridor, a confidential competitive process typically lifts terms by one to two turns of EBITDA over a single-bidder negotiation.

Sell Your Veterinary Practice: Michigan and beyond

Companion guides for Michigan sellers:

• Sell Your Veterinary Practice / Animal Hospital (national overview)
• Private Equity in Veterinary 2026: Active Platforms, Multiples, and Consolidation
• How to Sell a Veterinary Practice 2026
• Selling a Veterinary Specialty Hospital in 2026
• How to Prepare Your Veterinary Practice for a Sale or Exit (2026)
• How to Buy a Veterinary Practice in 2026 (Buyer’s Playbook)
• The lower middle market buyer mandate report
• Exit multiple: the 2026 operator’s guide

Michigan veterinary practice sale: 2026 outlook and key takeaways

Veterinary is one of the deepest consolidation pools in healthcare-adjacent services, and Michigan holds a stronger seat than its slow population growth implies. Cumulative private-equity investment reached $51.6 billion over 2017 to 2023 with another $9.3 billion in early 2024 (American Economic Liberties Project), 15-plus national platforms compete alongside Mars permanent capital, and a structural seller wave is building as 61% of clinical-practice DVMs plan to cut clinical hours within five years (JAVMA 2024-2025). A Michigan hospital with four to eight doctors, wellness penetration past 12 to 15%, normalized production comp, a current Michigan Board of Veterinary Medicine license and DEA registration, a prepared friendly-PC and MSO plan, clean real-estate optionality, and non-competes drafted to the MCL 445.774a standard can realistically reach the upper end of its 9.5x to 11.5x tier, with multi-site groups reaching 12x to 15x. The things that most often cost Michigan sellers money are an unprepared production-comp recut, misreading why the state restricts ownership and leaving the friendly-PC and MSO until late, outreach to stale buyer lists, ignoring the antitrust look in specialty-dense metros, and accepting the first offer instead of running the southern corridor as the competitive process it can be.

This guide reflects 2026 veterinary M&A conditions and CT Acquisitions direct work with active acquirers. Multiples are directional, not a guarantee; every practice is underwritten on its own doctor roster, wellness-plan penetration, adjusted EBITDA, real-estate optionality and growth profile. Michigan veterinary licensing under Public Health Code Part 188, the professional-corporation rule at MCL 450.1283, Michigan Board of Veterinary Medicine ownership-change notification, DEA registration transfer, Michigan non-compete standards under MCL 445.774a, the 2022 FTC JAB / SAGE consent order, the May 2024 FTC / DOJ serial-acquisitions RFI, and Michigan tax provisions are all subject to change; confirm current requirements with qualified Michigan veterinary counsel before relying on them in a transaction.

Related sale guides for Michigan sellers

If you operate a different business in Michigan, our state-specific sub-guides walk through the named PE buyers, current valuation multiples, and Michigan-specific deal mechanics for each vertical. You can also explore veterinary practice sales in other high-activity states.

Other Michigan industry sale guides

• Sell a CPA / accounting firm in Michigan
• Sell a RIA / wealth management firm in Michigan
• Sell an insurance agency in Michigan
• Sell a managed IT / MSP business in Michigan
• Sell a Commercial HVAC business in Michigan
• Sell Your Michigan Business (state hub with all verticals)

Veterinary practice sales in other states

• Texas
• California
• Florida

Michigan veterinary practice sale: frequently asked questions